Category Archives: CCSVI

IN BRIEF: Zocor Shown to Slow Disability in Secondary Progressive Multiple Sclerosis

IN BRIEF: Zocor Shown to Slow Disability in Secondary Progressive Multiple Sclerosis

The possible benefits of statin drugs against Multiple Sclerosis ( MS) have been investigated for years, not necessarily with success. Wang and colleagues concluded [1]: “There is no convincing evidence to support the use of either atorvastatin or simvastatin as an adjunctive therapy in MS.” But this was as a supplement …Read the Rest

IN DEPTH: Multiple Sclerosis Research And The Blood Brain Barrier

IN DEPTH: Multiple Sclerosis Research And The Blood Brain Barrier

The Blood Brain Barrier (BBB) is a main focus of Multiple Sclerosis research.  There are currently two main directions for that research: Control of the entry into  the brain of the immune system T-cell crossing through the impaired BBB Sending drugs into the brain directly by overriding the BBB An …Read the Rest

MND BRIEF: Multiple Sclerosis: Beta interferons (β-IFNs) might not slow disability progression

MND BRIEF: Multiple Sclerosis: Beta interferons (β-IFNs) might not slow disability progression

A new study by the University of British Columbia casts doubt on the benefits of the Interferon treatment against Relapsing-Remitting Multiple Sclerosis Here is the YouTube video from the press release The video tries to mitigate the setback with warm fuzzy statements about future research, but the tone of the …Read the Rest

© 2013-2019 Medical News Digest All Rights Reserved